Quarterly report pursuant to Section 13 or 15(d)

Revenue Recognition (Details)

v3.10.0.1
Revenue Recognition (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Total revenues $ 1,646,335 $ 1,976,005 $ 3,269,702 $ 3,983,077
Service and Other Revenues [Member]        
Total revenues 233,736 83,367 318,504 168,224
Rental, Service, Installation, Training, Shipping And Other [Member]        
Total revenues 71,736 83,367    
Capital equipment and other Biologics and drug delivery [Member]        
Total revenues     156,504 168,224
Biologics and drug delivery [Member]        
Total revenues 162,000 162,000
Product Revenue [Member]        
Total revenues 1,412,599 1,892,638 2,951,198 3,814,853
Functional Neurology [Member]        
Total revenues 1,159,527 1,343,425 2,338,862 2,931,867
Biologics And Drug Delivery [Member]        
Total revenues 111,792 92,479 292,258 167,486
Capital Equipment [Member]        
Total revenues $ 141,280 $ 456,734 $ 320,078 $ 715,500